Bristol Myers Squibb Completes $7.5 Billion Tender Offer for Outstanding Notes

Kirkland & Ellis has advised Bristol Myers Squibb Company. Bristol Myers Squibb Company(NYSE: BMY), a global pharmaceutical company, has completed a concurrent tender offer valued at…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here